Bebin is co-director of the UAB Tuberous Sclerosis Clinic and a founding member of the TSC Clinical Research Consortium.
UAB Neurology study adds to evidence that massive, second-wave reaction kills nerve cells.
The finding may help to avert more of the bleeds and blood clots that come when a patient’s starting dose misses the drug’s narrow safety window.
UAB expands research into dystonia with a generous gift from the Joel Johnson family.
A UAB study suggests that the Mediterranean diet, which urges consuming foods that contain omega-3 fatty acids found in fish, chicken and salad dressing, may be linked to preserving memory.
New marker predicts how resistant each patient’s brain cancer will be to chemotherapy.
Study authors say manipulating hormonal signals could effectively counter age-related cognitive decline.
He has been an active member of the American Parkinson Disease Association Scientific Advisory Board since May 2001 and is the board’s fourth chairman since the organization’s founding in 1961.
Kline has been a faculty member with the UAB Department of Ophthalmology since 1979, and has been professor of ophthalmology and associate professor of Neurology and Neurosurgery since 1990.
UAB researchers have identified a set of experimental drugs called LRRK2 inhibitors that may go beyond symptom relief to directly counter the inflammation and nerve cell death at the root of Parkinson’s disease.